0       0

2015 ISHLT Annual Meeting and Scientific Sessions


CCS38f - CONCURRENT SESSION 38: Cloudy with a Chance of T-Cells: Rejection Forecast -- The Time Course of Development of Anti-Human Leukocyte Antigen Antibodies Crucial for Monitoring and Potential Intervention Following Heart Transplantation


Apr 17, 2015 5:45pm ‐ Apr 17, 2015 6:00pm

Description

Presentation Includes
 

  • A Novel Human Leukocyte Antigen Score Improves Prediction for Rejection After Heart Transplant
  • Genetic Risk Score (GRS) Predicts Worse Survival in African American Heart Transplant Recipients at 10 Years
  • Donor-Derived Cell-Free DNA Decreases Following Effective Treatment of Acute Cellular Rejection in Heart Transplant Recipients: The CARGO II Multicenter Trial
  • Correlation of Longitudinal Gene-Expression Profiling (GEP) Score to Cytomegalovirus (CMV) Infection: Results From the Outcomes AlloMap® Registry (OAR)
  • Predictive Value of Gene Expression Profiling as Assessed By AlloMap® Score for Long-Term Survival After Heart Transplantation
  • The Time Course of Development of Anti-Human Leukocyte Antigen Antibodies Crucial for Monitoring and Potential Intervention Following Heart Transplantation

Speaker(s):

  • Jon Kobashigawa, MD, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, United States

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content